Showing
1 - 10
results of
10
for search '
Wu YL
'
Skip to content
Home
High Impact Articles
Search Options
UiTM Open Access
Search by UiTM Scopus
Advanced Search
Search by Category
Discovery Service
Sources
Jawi Collection
UiTM Journals
List UiTM Journal in IR
Statistic
About
Open Access
Creative Commons Licenses
COKI | Malaysia Open Access
Report Technical
User Guide
Contact Us
Search Tips
FAQs
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Author
Wu YL
Showing
1 - 10
results of
10
for search '
Wu YL
'
, query time: 0.23s
Refine Results
Sort
Relevance
Date Descending
Date Ascending
Call Number
Author
Title
1
Effect of Dose Adjustments on the Safety and Efficacy of Afatinib in Chinese Patients with EGFR-Mutated Non-Small Cell Lung Cancer Who Participated in the LUX-Lung Clinical Trial P...
by
Tu HY
,
Wu
YL
Published 2020-12-01
Get full text
Article
2
Personalized treatment strategies for non-small-cell lung cancer in Chinese patients: the role of crizotinib
by
Niu FY
,
Wu
YL
Published 2015-05-01
Get full text
Article
3
Prevalence of driver mutations in non-small-cell lung cancers in the People’s Republic of China
by
Gou LY,
Wu
YL
Published 2014-02-01
Get full text
Article
4
Survival Analysis of Antineoplastic Treatment for Older Patients with Metastatic Non-Small-Cell Lung Cancer: A Clinical Database Study
by
Yu CH
,
Cheng YA
,
Chen RY
,
Wu
YL
,
Lin MH
Published 2020-12-01
Get full text
Article
5
Inhibition of Mus81 by siRNA enhances sensitivity to 5-FU in breast carcinoma cell lines
by
Qian Y
,
Liu YN
,
Yan QY
,
Lv J
,
Ni XY
,
Wu
YL
,
Dong XJ
Published 2014-10-01
Get full text
Article
6
Familial association of lung cancer with liver cancer in first-degree relatives
by
Xu CR
,
Lin H
,
Su J
,
Zhang XC
,
Huang YS
,
Yang XN
,
Zhou Q
,
Yang JJ
,
Zhong WZ
,
Wu
YL
Published 2019-06-01
Get full text
Article
7
Abnormal Indexes of Liver and Kidney Injury Markers Predict Severity in COVID-19 Patients
by
Qu J
,
Zhu HH
,
Huang XJ
,
He GF
,
Liu JY
,
Huang JJ
,
Chen Y
,
Qu Q
,
Wu
YL
,
Chen XY
,
Lu Q
Published 2021-08-01
Get full text
Article
8
Afatinib versus gemcitabine/cisplatin for first-line treatment of Chinese patients with advanced non-small-cell lung cancer harboring EGFR mutations: subgroup analysis of the LUX-L...
by
Wu
YL
,
Xu CR
,
Hu CP
,
Feng J
,
Lu S
,
Huang Y
,
Li W
,
Hou M
,
Shi JH
,
Märten A
,
Fan J
,
Peil B
,
Zhou C
Published 2018-11-01
Get full text
Article
9
Hapten-enhanced therapeutic effect in advanced stages of lung cancer by ultra-minimum incision personalized intratumoral chemoimmunotherapy therapy
by
Yu BF
,
Lu YF
,
Gao F
,
Jing P
,
Han W
,
Zhang PC
,
Liu GL
,
Ru N
,
Cui GH
,
Xu XH
,
Sun CL
,
Guan CJ
,
Che YB
,
Wu
YL
,
Ma ZL
,
Fu Q
,
Liu J
,
Wang HY
Published 2015-01-01
Get full text
Article
10
Hapten-enhanced overall survival time in advanced hepatocellular carcinoma by ultro-minimum incision personalized intratumoral chemoimmunotherapy
by
Gao F
,
Jing P
,
Liu J
,
Lu YF
,
Zhang PC
,
Han W
,
Liu GL
,
Ru N
,
Cui GH
,
Sun CL
,
Che YB
,
Zhang HM
,
Hu QL
,
Wang HY
,
Wu
YL
,
Guan CJ
,
Fu Q
,
Ma ZL
,
Yu BF
Published 2015-06-01
Get full text
Article
Search Tools:
Get RSS Feed
—
Email this Search
Loading...